AwardTape · Defense awards · Medical · Drugs and biologicals · HT941026FE013
HT941026FE013: $276K delivery order to Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation holds a delivery order from Defense Health Agency with $276K obligated since Oct 2023, against a ceiling of $276K. Latest action Dec 19, 2025.
Pluvicto and lutathera injections
| PIID | HT941026FE013 |
|---|---|
| Type | delivery order |
| Parent award | 36F79720D0180 |
| Company | Novartis Pharmaceuticals Corporation |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY HCD WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $276K |
| Total obligated (lifetime) | $276K |
| Ceiling (base and all options) | $276K |
| Base date | Dec 19, 2025 |
| Latest action | Dec 19, 2025 |
| End date | Jan 2, 2026 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Full and open competition |
| Place of performance | NJ |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial